199 related articles for article (PubMed ID: 30882896)
1. Hydroxyurea (hydroxycarbamide) for transfusion-dependent β-thalassaemia.
Ansari SH; Lassi ZS; Khowaja SM; Adil SO; Shamsi TS
Cochrane Database Syst Rev; 2019 Mar; 3(3):CD012064. PubMed ID: 30882896
[TBL] [Abstract][Full Text] [Related]
2. Hydroxyurea for reducing blood transfusion in non-transfusion dependent beta thalassaemias.
Foong WC; Ho JJ; Loh CK; Viprakasit V
Cochrane Database Syst Rev; 2016 Oct; 10(10):CD011579. PubMed ID: 27755646
[TBL] [Abstract][Full Text] [Related]
3. Blood transfusion for preventing primary and secondary stroke in people with sickle cell disease.
Wang WC; Dwan K
Cochrane Database Syst Rev; 2013 Nov; (11):CD003146. PubMed ID: 24226646
[TBL] [Abstract][Full Text] [Related]
4. Hydroxyurea (hydroxycarbamide) for sickle cell disease.
Rankine-Mullings AE; Nevitt SJ
Cochrane Database Syst Rev; 2022 Sep; 9(9):CD002202. PubMed ID: 36047926
[TBL] [Abstract][Full Text] [Related]
5. Calcium channel blockers for preventing cardiomyopathy due to iron overload in people with transfusion-dependent beta thalassaemia.
Sadaf A; Hasan B; Das JK; Colan S; Alvi N
Cochrane Database Syst Rev; 2018 Jul; 7(7):CD011626. PubMed ID: 29998494
[TBL] [Abstract][Full Text] [Related]
6. Hydroxyurea (hydroxycarbamide) for sickle cell disease.
Nevitt SJ; Jones AP; Howard J
Cochrane Database Syst Rev; 2017 Apr; 4(4):CD002202. PubMed ID: 28426137
[TBL] [Abstract][Full Text] [Related]
7. Splenectomy for people with thalassaemia major or intermedia.
Sharma A; Easow Mathew M; Puri L
Cochrane Database Syst Rev; 2019 Sep; 9(9):CD010517. PubMed ID: 31529486
[TBL] [Abstract][Full Text] [Related]
8. Splenectomy for people with thalassaemia major or intermedia.
Easow Mathew M; Sharma A; Aravindakshan R
Cochrane Database Syst Rev; 2016 Jun; (6):CD010517. PubMed ID: 27296775
[TBL] [Abstract][Full Text] [Related]
9. Deferasirox for managing iron overload in people with thalassaemia.
Meerpohl JJ; Antes G; Rücker G; Fleeman N; Motschall E; Niemeyer CM; Bassler D
Cochrane Database Syst Rev; 2012 Feb; (2):CD007476. PubMed ID: 22336831
[TBL] [Abstract][Full Text] [Related]
10. Hematopoietic stem cell transplantation for people with β-thalassaemia.
Sharma A; Jagannath VA; Puri L
Cochrane Database Syst Rev; 2021 Apr; 4(4):CD008708. PubMed ID: 33880750
[TBL] [Abstract][Full Text] [Related]
11. Hematopoietic stem cell transplantation for people with ß-thalassaemia major.
Jagannath VA; Fedorowicz Z; Al Hajeri A; Hu N; Sharma A
Cochrane Database Syst Rev; 2011 Oct; (10):CD008708. PubMed ID: 21975785
[TBL] [Abstract][Full Text] [Related]
12. Psychological therapies for thalassaemia.
Anie KA; Massaglia P
Cochrane Database Syst Rev; 2014 Mar; 2014(3):CD002890. PubMed ID: 24604627
[TBL] [Abstract][Full Text] [Related]
13. Hematopoietic stem cell transplantation for people with ß-thalassaemia major.
Jagannath VA; Fedorowicz Z; Al Hajeri A; Sharma A
Cochrane Database Syst Rev; 2014 Oct; (10):CD008708. PubMed ID: 25316103
[TBL] [Abstract][Full Text] [Related]
14. Hematopoietic stem cell transplantation for people with ß-thalassaemia major.
Jagannath VA; Fedorowicz Z; Al Hajeri A; Sharma A
Cochrane Database Syst Rev; 2016 Nov; 11(11):CD008708. PubMed ID: 27900772
[TBL] [Abstract][Full Text] [Related]
15. Blood transfusions for treating acute chest syndrome in people with sickle cell disease.
Dastgiri S; Dolatkhah R
Cochrane Database Syst Rev; 2016 Aug; (8):CD007843. PubMed ID: 27574910
[TBL] [Abstract][Full Text] [Related]
16. Blood transfusions for treating acute chest syndrome in people with sickle cell disease.
Dolatkhah R; Dastgiri S
Cochrane Database Syst Rev; 2020 Jan; 1(1):CD007843. PubMed ID: 31942751
[TBL] [Abstract][Full Text] [Related]
17. Magnesium for treating sickle cell disease.
Than NN; Soe HHK; Palaniappan SK; Abas AB; De Franceschi L
Cochrane Database Syst Rev; 2017 Apr; 4(4):CD011358. PubMed ID: 28409830
[TBL] [Abstract][Full Text] [Related]
18. Regular long-term red blood cell transfusions for managing chronic chest complications in sickle cell disease.
Estcourt LJ; Fortin PM; Hopewell S; Trivella M; Hambleton IR; Cho G
Cochrane Database Syst Rev; 2016 May; (5):CD008360. PubMed ID: 27198469
[TBL] [Abstract][Full Text] [Related]
19. Psychological therapies for thalassaemia.
Anie KA; Massaglia P
Cochrane Database Syst Rev; 2001; (3):CD002890. PubMed ID: 11687031
[TBL] [Abstract][Full Text] [Related]
20. Preconception risk assessment for thalassaemia, sickle cell disease, cystic fibrosis and Tay-Sachs disease.
Hussein N; Weng SF; Kai J; Kleijnen J; Qureshi N
Cochrane Database Syst Rev; 2015 Aug; 2015(8):CD010849. PubMed ID: 26264938
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
